Charlotte's Web Holdings (CWBHF) Net Income towards Common Stockholders (2021 - 2026)

Charlotte's Web Holdings (CWBHF) reported Net Income towards Common Stockholders of -$13.1 million for Q1 2026, down 111.08% year-over-year from $118.4 million in Q1 2025, and down 14.79% quarter-over-quarter from -$11.4 million in Q4 2025.

Charlotte's Web Holdings (CWBHF) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Charlotte's Web Holdings (CWBHF) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$13.1 million in Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at -$13.1 million, down 111.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$36.6 million (down 38.67% YoY), and the FY2025 annual result was -$29.7 million, changed 0.35% from the prior year.
  • Net Income towards Common Stockholders fell to -$13.1 million in Q1 2026 per CWBHF's latest filing, from -$11.4 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $2.8 million in Q2 2023 and troughed at -$35.2 million in Q4 2022.
  • A 5-year average of -$9.2 million and a median of -$7.9 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders sank 876.58% in 2022, then surged 136.14% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$35.2 million in 2022, then jumped by 75.63% to -$8.6 million in 2023, then soared by 60.77% to -$3.4 million in 2024, then tumbled by 239.16% to -$11.4 million in 2025, then retreated by 14.79% to -$13.1 million in 2026.
  • Business Quant data shows CWBHF's Net Income towards Common Stockholders at -$13.1 million in Q1 2026, -$11.4 million in Q4 2025, and -$5.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 Charlotte's Web Holdings - - 5.20 Mn -13.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.11 Mn
Dec 31, 2025 -11.42 Mn
Sep 30, 2025 -5.82 Mn
Jun 30, 2025 -6.29 Mn
Mar 31, 2025 -6.21 Mn
Dec 31, 2024 -3.37 Mn
Sep 30, 2024 -5.79 Mn
Jun 30, 2024 -11.06 Mn
Mar 31, 2024 -9.63 Mn
Dec 31, 2023 -8.59 Mn
Sep 30, 2023 -15.14 Mn
Jun 30, 2023 2.84 Mn
Mar 31, 2023 -2.91 Mn
Dec 31, 2022 -35.23 Mn
Sep 30, 2022 -7.59 Mn
Jun 30, 2022 -7.87 Mn
Mar 31, 2022 -8.63 Mn
Dec 31, 2021 -118.25 Mn
Sep 30, 2021 -777,000.00
Jun 30, 2021 -5.92 Mn